PROJECT

Projects

Summary of Investment Information

Project Number

48381

Company Name

Sunshine Healthcare Lanka Limited

Date SPI Disclosed

Dec 2, 2024

Country

Sri Lanka

Region

South Asia

Projected Board Date

Apr 30, 2024

Environmental Category

B - Limited

Status

Active

Last Updated Date

Dec 2, 2024

Department

Regional Industry - MAS Asia & Pac

Industry

other

Previous Events

Approved : Apr 30, 2024
Signed : May 3, 2024
Invested : Sep 30, 2024

Sector

other

Project Description

Sunshine Healthcare Lanka Limited (“SHL” or “the Company”) is an integrated pharmaceutical player with operations across the value chain including (i) Pharma and Medical Devices import and distribution; (ii) Pharma Manufacturing; (iii) Pharma Retail (Pharmacies); and (iv) Distribution. The proposed IFC investment is an equity investment of up to LKR 3,270 million in SHL to support the Company in its growth plan to increase its pharma manufacturing capacity, augment its medical devices import segment, and expand its pharma retail footprint over the next three years (the Project).                                 

Sponsor / Cost / Location

Development Impact

E&S Category Rationale / Risks and Mitigation